Biolase (NSDQ:BIOL) today announced that it has appointed John Beaver as president and CEO, effective immediately.
Beaver replaces Todd Norbe, who has served as president and CEO since August 2018. Beaver previously served as the company’s executive VP, chief operating officer and chief financial officer.
“John’s knowledge of the dental industry, combined with his executive management and financial expertise, make him ideal to lead Biolase as we pursue our growth plans,” chairperson of the board Jonathan Lord said in a news release. “Since joining Biolase in 2017, John has spent considerable time in the field with dentists and our sales team ensuring that we are meeting the needs of the dental market. It is this hands-on approach that enabled John to develop and lead our Waterlase Exclusive Trial Program, which is off to a great start in 2021. Additionally, he has been heavily involved in our marketing efforts, and most recently launched our collaboration with the BMW Performance Center West.”
Beaver joined Biolase in 2017 as senior VP and chief financial officer. He has held numerous leadership roles at Biolase, including interim CEO until Norbe was appointed.
“This is a critically important time for Biolase, and I want to thank the board of directors for entrusting me to lead the company during this growth phase,” Beaver said. “As dental practitioners adapt to the current COVID-19 pandemic, it is clear they are turning to Biolase to help them ensure their patients are being cared for in a safe environment, as well as to help them grow their business. The success of our recent financings ensures we have the resources to execute our growth plan. We are well-positioned with our industry-leading products and the strong team we have assembled. I look forward to working closely with them to achieve Biolase’s full potential.”